References
- 1. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular andmolecular view point. J Am Soc Nephrol. 2006; 17: 1112-1127.
- 2. Lee T,Roy-Chaudhury P.Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis. 2009; 16: 329-338.
- 3. Oncevski A, Dejanov P, et al: Vascular access and chronic renal failure. ANN UROL, 34(5), 2000; pp. 345-351.
- 4. Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis. JAMA. 2008; 299: 2164-2171. [PubMed: 18477783]
- 5. Ernandez T, Saudan P, Berney T, et al. Risk factors for early failure of native arteriovenous fistulas. Nephron Clin Pract. 2005; 101: c39-c44.
- 6. Monroy-Cuadros M, Yilmaz S, Salazar-Banuelos A, et al. Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol. 2010; 5: 1787-1792.
- 7. Wasse H, Huang R, Naqvi N, Smith E, Wang D, Husain A Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients. J Vasc Access. 2012 Apr- Jun; 13(2): 168-74.
- 8. Lee T., Novel paradigms for dialysis vascular access: downstream vascular biology - is there a final common pathway? Clin J Am Soc Nephrol. 2013; 8: 2194-2201.
- 9. Duque JC, Vazquez-Padron RI. Myofibroblasts: the ideal target to prevent arteriovenous fistula failure? Kidney Int. 2014 Feb; 85(2): 234-6.
- 10. Roy- Chaudhury P, Arend L, Zhang J et al. Neointimal Hyperplasia in Early Arteriovenous Fistula Failure. Am J Kidney Disease. 2007; 50: 782-770.
- 11. Tellides G, Tereb DA, Kirkiles-Smith NC, et al: Interferon-Gamma elicits arteriosclerosis in the absence of leukocytes. Nature. 403: 207-211, 2000.
- 12. Porreca E, Di Febbo C, Mincione G, et al: Increased TGF-b production and gene expression by peripheral blood monocytes of hypertensive patients. Hypertens. 1997; 30: 134-139.
- 13. Shi Y, O’Brien JE Jr, Mannion JD, et al.. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblast. Circulation. 1997; 95: 2684-2693.
- 14. Shi Y, Pieniek M, Fard A, et al. Adventitial remodeling after coronary arterial injury. Circulation. 1996; 93: 340-348.
- 15. Sata MYH, Nagai R. Circulating recipient cells contribute to graft coronary arteriolosclerosis. J Cardiol. 2002; 39: 48-49.
- 16. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995; 75: 487-517.